Related Experiment Videos
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease
Susanne Ostrowitzki1, Robert A Lasser2, Ernest Dorflinger3
1Product Development, Neuroscience, Genentech Inc., South San Francisco, CA, USA.
Alzheimer'S Research & Therapy
|September 29, 2018
Abstract:
Following publication of the original article [1], the author reported errors in the formatting of the table. The details of the errors are as follows.